Breast Neoplasms: all 12,828 studies
Page 66 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.
- Patient Recall of Cancer Screening and DiagnosisWithdrawnNCT05014295Not applicable
- Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsTerminatedNCT05013554Phase 1
- Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate CancerCompletedNCT05012813Not applicable
- An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer SurvivorsCompletedNCT05012176Not applicable
- Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant ChemotherapyCompletedNCT05011721Not applicable
- Prevalence of Depression and Anxiety Among Breast Cancer PatientsCompletedNCT05011409
- Role of Exercise in Breast Cancer Patient Undergoing TreatmentActive, not recruitingNCT05009849Not applicable
- P2 Clinical Efficacy & Safety Study of V-111 Monotherapy & Sacituzumab Govitecan-hziy/V-111 Combo Therapy for mTNBC .WithdrawnNCT05008510Phase 2
- Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast CancerStatus unknownNCT05007444Phase 2
- Contrast-Free Magnetic Resonance Imaging for Breast DiseaseActive, not recruitingNCT05006196
- Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response AssessmentWithdrawnNCT05005936
- Study of Efficacy, Safety, and Pharmacokinetics of FCN-437c in Combination With Fulvestrant or Letrozole+GoserelinStatus unknownNCT05004142Phase 2
- Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid TumorsCompletedNCT05002868Phase 1
- Comparative Effectiveness of Palbociclib Plus AI Versus Fulvestrant for HR+/HER2- ABCStatus unknownNCT05000736
- Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved PopulationsCompletedNCT05000502Not applicable
- Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast CancerCompletedNCT04999917Not applicable
- Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast CancerStatus unknownNCT04999540Phase 2
- Prospective Evaluation of Targeted Axillary Dissection (TAD)CompletedNCT04998682Not applicable
- Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer PatientsActive, not recruitingNCT04997941Phase 2
- Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast CancerStatus unknownNCT04997798Phase 2
- Breast Cancer, Omics, and Precision MedicineStatus unknownNCT04996836Phase 2
- Dissecting the Pathways of Therapy Resistance in Early Breast CancerTerminatedNCT04995575
- Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm (ASLAN) StudyActive, not recruitingNCT04993625Not applicable
- Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE StudyActive, not recruitingNCT04993313Not applicable
- A PK Study of Oraxol in Breast Cancer PatientsCompletedNCT04993040Phase 1
- Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ETCompletedNCT04992156
- A Study of ART4215 for the Treatment of Advanced or Metastatic Solid TumorsCompletedNCT04991480Phase 1
- Experimental Study About Physiotherapy Treatment vs Self-treatment In Axillary Web Syndrome After Axillary DissectionCompletedNCT04990960Not applicable
- Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine ModalitiesCompletedNCT04990934
- A Research Study to Collect Patient Reported Outcomes Using Electronic SurveysTerminatedNCT04990895Not applicable
- Incidence and Factors Affecting the Development and Outcome of Post Mastectomy Pain SyndromeActive, not recruitingNCT04989179
- Prevalence of Lymphedema in Valle Del Cauca, Colombia.Status unknownNCT04987424
- The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer PatientsStatus unknownNCT04986306
- Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWithdrawnNCT04985357
- Correlation of Predictive Accuracy of PREDICT Version 2.2 of Indian Women With Operable Breast CancerStatus unknownNCT04985253
- Apollo Device for Metastatic Breast Cancer (MBC)CompletedNCT04983342Not applicable
- A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor CancerTerminatedNCT04982926Phase 1
- Korea Post Marketing Surveillance (PMS) Study of Talzenna®WithdrawnNCT04982848
- Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile SoftwareCompletedNCT04980989Not applicable
- A Nutritional Intervention and Physical Activity Program Reduce Body Weight in Women Newly Diagnosed With Breast Cancer.CompletedNCT04980118Not applicable
- The Effect of Early Rehabilitation After Breast Cancer Surgery on Physical and Psychosocial FunctionsCompletedNCT04979715Not applicable
- Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal MicroscopeCompletedNCT04976556
- ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast CancerStatus unknownNCT04975451Phase 2
- Tear Based Sample Collection Breast Cancer DetectionActive, not recruitingNCT04974567
- Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast CancerSuspendedNCT04973930Phase 3
- Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus BiosimilarsCompletedNCT04971304
- A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursActive, not recruitingNCT04969835Phase 1
- A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world SettingTerminatedNCT04967248
- Investigation of a Digital Healthy Habits Program for Individuals With Breast CancerCompletedNCT04967209
- Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53CompletedNCT04966923
- Nurse Navigation Program Based On Health Belief Model In Breast Cancer Screening (NaHeB-CaS)CompletedNCT04966377Not applicable
- Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Active, not recruitingNCT04964934Phase 3
- RWS of Inetetamab HER2 Positive Advanced Breast CancerStatus unknownNCT04963608
- Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast CancerStatus unknownNCT04963595Phase 2
- Breast Cancer Liquid Biopsy TrialStatus unknownNCT04962529
- Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer PatientsStatus unknownNCT04962425
- A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)Active, not recruitingNCT04961996Phase 3
- Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376Active, not recruitingNCT04961632Phase 1
- Evaluation of Heart Function in Breast Cancer Patients Using TrastuzumabStatus unknownNCT04961307
- Personalized Follow-up After Breast Cancer Surgery Via Electronic Patient Reported OutcomesCompletedNCT04957186Not applicable
- Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing SurgerySuspendedNCT04955808
- PFMT Educational Intervention for Patients With Advancer Breast CancerStatus unknownNCT04953377Not applicable
- Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node BiopsyCompletedNCT04951245Phase 3
- High-intensity Exercise After TreatmentTerminatedNCT04950010Not applicable
- Artificial Intelligence in Breast Cancer Screening ProgramsCompletedNCT04949776Not applicable
- The Effect of a Patient Decision Aids for Breast Cancer ScreeningStatus unknownNCT04948983Not applicable
- Axillary Lymph Node Tattoo Marking StudyTerminatedNCT04947917Not applicable
- A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast CancerSuspendedNCT04946864Phase 1/2
- Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2')Status unknownNCT04946227Phase 2
- A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in RussiaCompletedNCT04943497
- A Study in Patients With Advanced Breast CancerTerminatedNCT04942054Phase 1
- Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal WomenCompletedNCT04940026Phase 1
- TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)CompletedNCT04936243Not applicable
- Adjustable Compression Wrap Versus Compression Bandage Reduce to Breast Cancer-related LymphedemaCompletedNCT04934098Not applicable
- Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node BiopsyStatus unknownNCT04932460Not applicable
- Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsTerminatedNCT04931823Phase 1
- ARTISS a Single-centre Randomised Control StudyCompletedNCT04931615Phase 4
- A Prospective Single-center Cohort Study "Preoperative Identification of Sentinel Lymph Nodes Using Contrast-enhanced CT Lymphography in Breast Cancer Patients"Status unknownNCT04930692Not applicable
- COVID-19 Pandemic: Effect on Management of Patients With Breast CancerCompletedNCT04929964
- Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With 3D PrintingStatus unknownNCT04929197Not applicable
- Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic TherapyActive, not recruitingNCT04928261Phase 4
- Self-applied Acupressure for Arthralgia-fatigue-sleep Disturbance in Breast CancerTerminatedNCT04927910Phase 2
- Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyTerminatedNCT04927559
- A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast CancerTerminatedNCT04927481Phase 2
- Retrospective Comparative in Vitro Case-controlled Study of the Liquid Biopsy Test System in Women With Breast CancerStatus unknownNCT04927130
- 3D Ultrasound Microvessel Imaging for Breast MassesCompletedNCT04925817Early Phase 1
- Study of XB002 in Subjects With Solid Tumors (JEWEL-101)CompletedNCT04925284Phase 1
- A Study of MRG002 in the Treatment of Patients With HER2-positive Unresectable Locally Advanced or Metastatic Breast CancerStatus unknownNCT04924699Phase 2/3
- Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer PatientsCompletedNCT04924010Not applicable
- Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA SuppressionActive, not recruitingNCT04920708Phase 2
- Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast CancerCompletedNCT04920656
- Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in MartiniqueActive, not recruitingNCT04918082
- Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast CancerStatus unknownNCT04917900Phase 2
- Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf RegionCompletedNCT04916509
- The Effect of Training Given by Mobile Application to Women Undergoing Breast SurgeryCompletedNCT04914780Not applicable
- Cancer Predictive Score on Breast MRIStatus unknownNCT04914494
- Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II StudyStatus unknownNCT04913571Phase 2
- Hypofractionation With Simultaneous Integrated Boost for Early Breast CancerCompletedNCT04913532Not applicable
- Trajectory Analysis of Symptom Distress and Cancer-related Fatigue After Adjuvant Chemotherapy in Breast Cancer FemaleStatus unknownNCT04911699
- MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast CancerCompletedNCT04909554